AIRS

AirSculpt Technologies, Inc. operates a national chain of specialty cosmetic surgery centers focused on body contouring procedures. Headquartered in Miami, Florida, the company performs minimally invasive fat removal and body sculpting treatments using its proprietary AirSculpt technology, which removes unwanted fat without using a scalpel, needle, stitches, or general anesthesia. The company operates approximately 20 centers across major metropolitan markets in the United States, targeting health-conscious consumers seeking aesthetic enhancement with minimal downtime. AirSculpt's flagship procedures include treatments for the abdomen, flanks, back, arms, thighs, and chin, as well as fat transfer procedures such as the Brazilian Butt Lift. The company differentiates itself through its patented technology platform, which claims to offer more precise results and faster recovery times compared to traditional liposuction methods. AirSculpt went public in October 2021 through an initial public offering. The company operates on a direct-to-consumer marketing model, utilizing digital advertising and social media to attract patients, and generates revenue primarily through cash-pay procedures not typically covered by insurance. Each center is staffed by board-certified physicians trained in the AirSculpt technique, and the company maintains centralized oversight of clinical protocols, marketing, and operational standards across its network.